Gilead Sciences, Inc.
333 Lakeside Drive
About Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
2107 articles with Gilead Sciences, Inc.
Gilead Sciences, Inc. to Present at the Cowen & Company 27th Annual Health Care Conference on Monday, March 12
Gilead Sciences, Inc. Announces New Appointments Within Executive Team
New AIDS Drugs Offer Hope for Long-Term Patients
Gilead Sciences, Inc. Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137
Gilead Sciences, Inc. (Jobs) Study Meets Primary Endpoint of Non-inferiority
The Day In Review: Sanofi-Aventis (France) Loses Lovenox Patent
Gilead Sciences, Inc. To Present At The Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference On Wednesday, February 7
Gilead Sciences, Inc. Announces Fourth Quarter And Full Year 2006 Financial Results
Gilead Sciences, Inc. Announces Senior Management Promotion
Gilead Sciences, Inc. To Release Fourth Quarter And Year End 2006 Financial Results On Wednesday, January 31, 2007
Carla A. Hills Joins Gilead Sciences, Inc.'s Board Of Directors
Gilead Sciences (Foster City, CA) To Present At The 25th Annual JPMorgan Healthcare Conference On Monday, January 8th
Gilead Sciences (Foster City, CA) Submits New Drug Application To U.S. FDA For Ambrisentan For The Treatment Of Pulmonary Arterial Hypertension
96-Week Data From Gilead Sciences (Foster City, CA)'s Study 934 Comparing Viread(R) And Emtriva(R) To Combivir® Both In Combination With Sustiva(R) Published In Journal Of Acquired Immune Deficiency Syndrome
Gilead Sciences (Foster City, CA) Grants Intellectual Property Rights For Tenofovir Topical Gel To The International Partnership For Microbicides And CONRAD
Gilead Sciences (Foster City, CA) Receives Subpoena From U.S. Department Of Justice
Gilead Sciences (Foster City, CA) To Present At The NASDAQ 18th Investor Program On Thursday, December 7
Gilead Sciences (Foster City, CA) To Present At Two Upcoming Investor Conferences
Gilead Sciences (Foster City, CA) Completes Acquisition Of Myogen
Gilead Sciences (Foster City, CA) To Present At The Credit Suisse Healthcare Conference On Friday, November 17th